These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Overview of pathophysiology and rationale for treatment of sickle cell anemia. Rodgers GP Semin Hematol; 1997 Jul; 34(3 Suppl 3):2-7. PubMed ID: 9317195 [TBL] [Abstract][Full Text] [Related]
4. Pathophysiology and therapy for haemoglobinopathies. Part I: sickle cell disease. Madigan C; Malik P Expert Rev Mol Med; 2006 Apr; 8(9):1-23. PubMed ID: 16690007 [TBL] [Abstract][Full Text] [Related]
5. Effect of alpha-globin genotype on the pathophysiology of sickle cell disease. Ballas SK Pediatr Pathol Mol Med; 2001; 20(2):107-21. PubMed ID: 12673836 [TBL] [Abstract][Full Text] [Related]
6. [Sickle cell disease in the Netherlands]. Statius van Eps LW Ned Tijdschr Geneeskd; 1984 Jun; 128(25):1196-8. PubMed ID: 6462267 [No Abstract] [Full Text] [Related]
7. High oxygen environment during pregnancy rescues sickle cell anemia mice from prenatal death. Ye L; Chang JC; Lu R; Kan YW Blood Cells Mol Dis; 2008; 41(1):67-72. PubMed ID: 18207438 [TBL] [Abstract][Full Text] [Related]
8. [Contribution to the clinical data of sickle cell anemia-thalassemia]. Honetz N; Fischer M; Pesendorfer F Med Welt; 1965 Oct; 43():2424-8. PubMed ID: 5880079 [No Abstract] [Full Text] [Related]
9. Role of epistatic (modifier) genes in the modulation of the phenotypic diversity of sickle cell anemia. Nagel RL; Steinberg MH Pediatr Pathol Mol Med; 2001; 20(2):123-36. PubMed ID: 12673837 [TBL] [Abstract][Full Text] [Related]
10. Fetal health assessment in pregnancies complicated by sickle hemoglobinopathies. Morrison JC; Blake PG; McCoy C; Martin JN; Wiser WL Obstet Gynecol; 1983 Jan; 61(1):22-4. PubMed ID: 6823346 [TBL] [Abstract][Full Text] [Related]
12. Human fetal hemoglobin: significance in disease. Bertles JF Ann N Y Acad Sci; 1974 Nov; 241(0):638-52. PubMed ID: 4611309 [No Abstract] [Full Text] [Related]
13. Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece. Loukopoulos D; Voskaridou E; Kalotychou V; Schina M; Loutradi A; Theodoropoulos I Blood Cells Mol Dis; 2000 Oct; 26(5):453-66. PubMed ID: 11112383 [TBL] [Abstract][Full Text] [Related]
14. Sickle cell disease: a multigenic perspective of a single gene disorder. Kutlar A Hemoglobin; 2007; 31(2):209-24. PubMed ID: 17486504 [TBL] [Abstract][Full Text] [Related]
15. Sickling of nucleated erythroid precursors from patients with sickle cell anemia. Hasegawa S; Rodgers GP; Dwyer N; Noguchi CT; Blanchette-Mackie EJ; Uyesaka N; Schechter AN; Fibach E Exp Hematol; 1998 Apr; 26(4):314-9. PubMed ID: 9546314 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological induction of fetal hemoglobin: Why haven't we been more successful in thalassemia? Fathallah H; Sutton M; Atweh GF Ann N Y Acad Sci; 2005; 1054():228-37. PubMed ID: 16339670 [TBL] [Abstract][Full Text] [Related]
17. Concordant fetal hemoglobin response to hydroxyurea in siblings with sickle cell disease. Steinberg MH; Voskaridou E; Kutlar A; Loukopoulos D; Koshy M; Ballas SK; Castro O; Barton F Am J Hematol; 2003 Feb; 72(2):121-6. PubMed ID: 12555216 [TBL] [Abstract][Full Text] [Related]
18. Iron loading and endocrine functions in nontransfused patients with beta-thalassemia intermedia or sickle-cell thalassemia. Flatau E; Resnitzky P; Kauffman N; Harpaz S; Kohn D Isr J Med Sci; 1981 Jan; 17(1):22-7. PubMed ID: 7461943 [TBL] [Abstract][Full Text] [Related]
19. Pathophysiologically based drug treatment of sickle cell disease. Steinberg MH Trends Pharmacol Sci; 2006 Apr; 27(4):204-10. PubMed ID: 16530854 [TBL] [Abstract][Full Text] [Related]